"Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture"

  • Cecilia Menna
  • , Elena De Falco
  • , Luca Pacini
  • , Gaia Scafetta
  • , Paola Ruggieri
  • , Rosa Puca
  • , Vincenzo Petrozza
  • , Anna Maria Ciccone
  • , Erino Angelo Rendina
  • , Antonella Calogero
  • , Mohsen Ibrahim

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Fetal lung adenocarcinoma (FLAC) is a rare variant of lung adenocarcinoma. Studies regarding FLAC have been based only on histopathological observations, thus representative in vitro models of FLAC cultures are unavailable. We have established and characterized a human primary FLAC cell culture, exploring its biology, chemosensitivity, and migration. FLAC cells and specimen showed significant upregulation of VEGF165 and HIF-1α mRNA levels. This observation was confirmed by in vitro chemosensitivity and migration assay, showing that only Axitinib was comparable to Cisplatin treatment. We provide a suitable in vitro model to further investigate the nature of this rare type of cancer.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalCancer Investigation
Volume32
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Antineoplastic drugs
  • Axitinib
  • Cancer primary cell cultures
  • Fetal lung adenocarcinoma
  • Lung adenocarcinoma
  • Vascular endothelial growth factor

Fingerprint

Dive into the research topics of '"Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture"'. Together they form a unique fingerprint.

Cite this